Raymond Anthony Isidro-Vega, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Verrucous | 1 | 2021 | 27 | 0.850 |
Why?
|
| Colon | 3 | 2017 | 1758 | 0.760 |
Why?
|
| Receptors, Calcitriol | 3 | 2020 | 351 | 0.730 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2019 | 2286 | 0.710 |
Why?
|
| Macrophages | 5 | 2020 | 5747 | 0.710 |
Why?
|
| Probiotics | 2 | 2017 | 342 | 0.600 |
Why?
|
| Colitis | 2 | 2022 | 1137 | 0.590 |
Why?
|
| Intestine, Small | 1 | 2021 | 1221 | 0.540 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2021 | 665 | 0.540 |
Why?
|
| Esophageal Neoplasms | 2 | 2022 | 1509 | 0.530 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2015 | 126 | 0.520 |
Why?
|
| Tissue Fixation | 1 | 2015 | 256 | 0.510 |
Why?
|
| Paraffin Embedding | 1 | 2015 | 318 | 0.510 |
Why?
|
| Formaldehyde | 1 | 2015 | 363 | 0.500 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 1245 | 0.450 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2646 | 0.400 |
Why?
|
| Immunohistochemistry | 3 | 2021 | 11665 | 0.290 |
Why?
|
| Colorectal Neoplasms | 2 | 2016 | 6588 | 0.280 |
Why?
|
| Enterocolitis | 1 | 2022 | 93 | 0.220 |
Why?
|
| Gastritis | 1 | 2022 | 183 | 0.210 |
Why?
|
| Prognosis | 1 | 2021 | 28987 | 0.200 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 153 | 0.180 |
Why?
|
| Ganciclovir | 1 | 2019 | 260 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2020 | 8525 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 9546 | 0.170 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2017 | 68 | 0.160 |
Why?
|
| Puerto Rico | 2 | 2016 | 354 | 0.160 |
Why?
|
| Mutation | 1 | 2021 | 29270 | 0.150 |
Why?
|
| Opportunistic Infections | 1 | 2019 | 389 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2017 | 3034 | 0.140 |
Why?
|
| Vitamin D | 2 | 2020 | 3194 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 761 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 1001 | 0.120 |
Why?
|
| Endometriosis | 1 | 2020 | 803 | 0.110 |
Why?
|
| Astrocytes | 1 | 2019 | 1233 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 630 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 777 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 1157 | 0.100 |
Why?
|
| Feces | 1 | 2017 | 1373 | 0.100 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 1939 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2015 | 1144 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 1512 | 0.100 |
Why?
|
| Male | 8 | 2021 | 350156 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2019 | 2807 | 0.080 |
Why?
|
| Hippocampus | 1 | 2019 | 3625 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2016 | 2595 | 0.080 |
Why?
|
| Acute Disease | 1 | 2017 | 7137 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 3991 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 1371 | 0.070 |
Why?
|
| Middle Aged | 5 | 2021 | 214618 | 0.070 |
Why?
|
| Biopsy | 2 | 2016 | 6732 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1787 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13635 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2020 | 4089 | 0.070 |
Why?
|
| Homeostasis | 1 | 2016 | 3330 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2020 | 4163 | 0.070 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 1819 | 0.060 |
Why?
|
| Aged | 4 | 2021 | 162383 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2016 | 2251 | 0.060 |
Why?
|
| Female | 7 | 2021 | 377052 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2015 | 8654 | 0.060 |
Why?
|
| Rats | 2 | 2019 | 24802 | 0.060 |
Why?
|
| Humans | 10 | 2022 | 715636 | 0.060 |
Why?
|
| Animals | 5 | 2020 | 169277 | 0.060 |
Why?
|
| Cytokines | 1 | 2017 | 7190 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2017 | 9028 | 0.050 |
Why?
|
| Inflammation | 1 | 2020 | 10091 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2016 | 21802 | 0.050 |
Why?
|
| Neurons | 1 | 2019 | 9377 | 0.050 |
Why?
|
| Adult | 5 | 2022 | 212228 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11665 | 0.040 |
Why?
|
| Phenotype | 1 | 2016 | 16308 | 0.040 |
Why?
|
| Uterus | 1 | 2020 | 678 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2022 | 1026 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 58288 | 0.030 |
Why?
|
| Diarrhea | 1 | 2022 | 1370 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 20514 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 963 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2104 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13620 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23721 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 961 | 0.030 |
Why?
|
| Fever | 1 | 2019 | 1586 | 0.030 |
Why?
|
| Headache | 1 | 2019 | 1152 | 0.030 |
Why?
|
| Viral Load | 1 | 2019 | 3281 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 80320 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 2222 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2022 | 13205 | 0.020 |
Why?
|
| Disease Progression | 1 | 2022 | 13219 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2019 | 19905 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 14878 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 72439 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 62037 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 56137 | 0.010 |
Why?
|